Home R&D Page 3

R&D

Phase 3 success for Pfizer & BioNTech’s COVID vaccine candidate
Featured

Phase 3 success for Pfizer & BioNTech’s COVID vaccine candidate

Dominic Cuthbert -
0
CEPI extends Clover partnership to fund COVID vaccine candidate development
Featured

CEPI extends Clover partnership to fund COVID vaccine candidate development

Dominic Cuthbert -
0
RCPE awarded two FDA contracts for next-gen pharma technology
Featured

RCPE awarded two FDA contracts for next-gen pharma technology

Dominic Cuthbert -
0
Optibrium enters cheminformatics collaboration with MSD
Featured

Optibrium enters cheminformatics collaboration with MSD

Tess Egginton -
0
Collaboration to develop next-generation CAR-T cell therapies
Featured

Collaboration to develop next-generation CAR-T cell therapies

Tess Egginton -
0
Boehringer Ingelheim and Oxford BioTherapeutics expand collaboration
Featured

Boehringer Ingelheim and Oxford BioTherapeutics expand collaboration

Dominic Cuthbert -
0
Moderna and Vertex to treat cystic fibrosis using gene editing
Featured

Moderna and Vertex to treat cystic fibrosis using gene editing

Dominic Cuthbert -
0
Takeda & Arrowhead to co-develop RNAi therapy for AATLD
Featured

Takeda & Arrowhead to co-develop RNAi therapy for AATLD

Dominic Cuthbert -
0
AstraZeneca’s long-acting antibody combo advances into Phase III clinical trials
Featured

AstraZeneca’s long-acting antibody combo advances into Phase III clinical trials

Dominic Cuthbert -
0
EMA starts first rolling review of COVID-19 vaccine
Featured

EMA starts first rolling review of COVID-19 vaccine

Dominic Cuthbert -
0
1234...179Page 3 of 179

© 2020 Part of the Business Link Magazine Group. Armstrong House, Armstrong Street, Grimsby,
North East Lincolnshire, DN31 2QE

About Us

Popular Category

Editor Picks